Literature DB >> 24642735

Evaluation of pharmacogenetic markers to predict the risk of Cisplatin-induced ototoxicity.

C Lanvers-Kaminsky1, I Malath1, D Deuster2, G Ciarimboli3, J Boos1, A G Am Zehnhoff-Dinnesen4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24642735     DOI： 10.1038/clpt.2014.67

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  5 in total

1.  Common variants in ACYP2 influence susceptibility to cisplatin-induced hearing loss.

Authors:  Heng Xu; Giles W Robinson; Jie Huang; Joshua Yew-Suang Lim; Hui Zhang; Johnnie K Bass; Alberto Broniscer; Murali Chintagumpala; Ute Bartels; Sri Gururangan; Tim Hassall; Michael Fisher; Richard Cohn; Tetsuji Yamashita; Tal Teitz; Jian Zuo; Arzu Onar-Thomas; Amar Gajjar; Clinton F Stewart; Jun J Yang
Journal:  Nat Genet       Date:  2015-02-09       Impact factor: 38.330

2.  Analytical Validation of Variants to Aid in Genotype-Guided Therapy for Oncology.

Authors:  Marelize Swart; Wesley M Stansberry; Victoria M Pratt; Elizabeth B Medeiros; Patrick J Kiel; Fei Shen; Bryan P Schneider; Todd C Skaar
Journal:  J Mol Diagn       Date:  2019-02-20       Impact factor: 5.568

3.  Promoter region variation in NFE2L2 influences susceptibility to ototoxicity in patients exposed to high cumulative doses of cisplatin.

Authors:  T F Spracklen; A A Vorster; L Ramma; S Dalvie; R S Ramesar
Journal:  Pharmacogenomics J       Date:  2016-07-26       Impact factor: 3.550

Review 4.  TPMT, COMT and ACYP2 genetic variants in paediatric cancer patients with cisplatin-induced ototoxicity.

Authors:  Daniel B Hawcutt; Munir Pirmohamed; Signe Thiesen; Peng Yin; Andrea L Jorgensen; Jieying Eunice Zhang; Valentina Manzo; Laurence McEvoy; Christopher Barton; Susan Picton; Simon Bailey; Penelope Brock; Harish Vyas; David Walker; Guy Makin; Srinivas Bandi; Barry Pizer
Journal:  Pharmacogenet Genomics       Date:  2017-06       Impact factor: 2.089

Review 5.  Pharmacogenomics in Pediatric Patients: Towards Personalized Medicine.

Authors:  Hedy Maagdenberg; Susanne J H Vijverberg; Marc B Bierings; Bruce C Carleton; Hubertus G M Arets; Anthonius de Boer; Anke H Maitland-van der Zee
Journal:  Paediatr Drugs       Date:  2016-08       Impact factor: 3.022
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.